kisplyx 10 mg capsule
eisai pharma ag - lenvatinibum - capsule - lenvatinibum 10 mg ut lenvatinibi mesilas, calcii carbonas, mannitolum, cellulosum microcristallinum, hydroxypropylcellulosum, hydroxypropylcellulosum substitutum humile, talcum, kapselhülle: hypromellosum, e 171, e 172 (flavum), e 172 (rubrum), drucktinte: lacca, e 172 (nigrum), kalii hydroxidum, propylenglycolum, pro capsula. - behandlung von fortgeschrittenem nierenzellkarzinom (rcc) - synthetika
kisplyx 4 mg capsules
eisai pharma ag - lenvatinibum - capsules - lenvatinibum 4 mg ut lenvatinibi mesilas, calcii carbonas, mannitolum, cellulosum microcristallinum, hydroxypropylcellulosum, hydroxypropylcellulosum substitutum humile, talcum, kapselhülle: hypromellosum, e 171, e 172 (flavum), e 172 (rubrum), drucktinte: lacca, e 172 (nigrum), kalii hydroxidum, propylenglycolum, pro capsula. - behandlung von fortgeschrittenem nierenzellkarzinom (rcc) - synthetika
kisplyx 10 mg capsules
eisai pharma ag - lenvatinibum - capsules - lenvatinibum 10 mg ut lenvatinibi mesilas, calcii carbonas, mannitolum, cellulosum microcristallinum, hydroxypropylcellulosum, hydroxypropylcellulosum substitutum humile, talcum, kapselhülle: hypromellosum, e 171, e 172 (flavum), e 172 (rubrum), drucktinte: lacca, e 172 (nigrum), kalii hydroxidum, propylenglycolum, pro capsula. - behandlung von fortgeschrittenem nierenzellkarzinom (rcc) - synthetika
kisplyx 4 mg
orifarm as - lenvatinibmesilat - kapsel, hard - 4 mg
kisplyx 10 mg 30 càpsules dures
kisplyx 4 mg 30 càpsules dures
kisplyx 10 mg
eisai gmbh - germania - lenvatinibum - caps. - 10mg - inhibitori de protein-kinaza
kisplyx 4 mg
eisai gmbh - germania - lenvatinibum - caps. - 4mg - inhibitori de protein-kinaza
keytruda
merck sharp & dohme d.o.o. - пембролизумаб -